References
1. Mena I, Nelson MI, Quezada-Monroy F, Dutta J, Cortes-Fernandez R,
Lara-Puente JH, et al. Origins of the 2009 H1N1 influenza pandemic in
swine in Mexico. Elife. 2016;5.
2. Novel Swine-Origin Influenza AVIT, Dawood FS, Jain S, Finelli L, Shaw
MW, Lindstrom S, et al. Emergence of a novel swine-origin influenza A
(H1N1) virus in humans. N Engl J Med. 2009;360(25):2605-15.
3. Dawood FS, Iuliano AD, Reed C, Meltzer MI, Shay DK, Cheng PY, et al.
Estimated global mortality associated with the first 12 months of 2009
pandemic influenza A H1N1 virus circulation: a modelling study. Lancet
Infect Dis. 2012;12(9):687-95.
4. Zhang W, Qi J, Shi Y, Li Q, Gao F, Sun Y, et al. Crystal structure of
the swine-origin A (H1N1)-2009 influenza A virus hemagglutinin (HA)
reveals similar antigenicity to that of the 1918 pandemic virus. Protein
Cell. 2010;1(5):459-67.
5. Igarashi M, Ito K, Yoshida R, Tomabechi D, Kida H, Takada A.
Predicting the antigenic structure of the pandemic (H1N1) 2009 influenza
virus hemagglutinin. PLoS One. 2010;5(1):e8553.
6. Lansbury LE, Smith S, Beyer W, Karamehic E, Pasic-Juhas E, Sikira H,
et al. Effectiveness of 2009 pandemic influenza A(H1N1) vaccines: A
systematic review and meta-analysis. Vaccine. 2017;35(16):1996-2006.
7. Kissling E, Pozo F, Buda S, Vilcu AM, Rizzo C, Gherasim A, et al.
Effectiveness of influenza vaccine against influenza A in Europe in
seasons of different A(H1N1)pdm09 and the same A(H3N2) vaccine
components (2016-17 and 2017-18). Vaccine X. 2019;3:100042.
8. Lackenby A, Hungnes O, Dudman SG, Meijer A, Paget WJ, Hay AJ, et al.
Emergence of resistance to oseltamivir among influenza A(H1N1) viruses
in Europe. Euro Surveill. 2008;13(5).
9. Meijer A, Lackenby A, Hungnes O, Lina B, van-der-Werf S, Schweiger B,
et al. Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08
season. Emerg Infect Dis. 2009;15(4):552-60.
10. Zhou B, Donnelly ME, Scholes DT, St George K, Hatta M, Kawaoka Y, et
al. Single-reaction genomic amplification accelerates sequencing and
vaccine production for classical and Swine origin human influenza a
viruses. J Virol. 2009;83(19):10309-13.
11. McCauley J, Rodney D, Lin YP, Xiang Z, Whittaker L, Halai C, et al.
Report prepared for the WHO annual consultation on the composition of
influenza vaccine for the Northern hemisphere 2019-2020. London; 2019
2019.
12. Yang H, Carney P, Stevens J. Structure and Receptor binding
properties of a pandemic H1N1 virus hemagglutinin. PLoS Curr.
2010;2:RRN1152.
13. Matrosovich M, Matrosovich T, Carr J, Roberts NA, Klenk HD.
Overexpression of the alpha-2,6-sialyltransferase in MDCK cells
increases influenza virus sensitivity to neuraminidase inhibitors. J
Virol. 2003;77(15):8418-25.
14. Hurt AC, Lee RT, Leang SK, Cui L, Deng YM, Phuah SP, et al.
Increased detection in Australia and Singapore of a novel influenza
A(H1N1)2009 variant with reduced oseltamivir and zanamivir sensitivity
due to a S247N neuraminidase mutation. Euro Surveill. 2011;16(23).
15. Caton AJ, Brownlee GG, Yewdell JW, Gerhard W. The antigenic
structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype).
Cell. 1982;31(2 Pt 1):417-27.
16. Brownlee GG, Fodor E. The predicted antigenicity of the
haemagglutinin of the 1918 Spanish influenza pandemic suggests an avian
origin. Philos Trans R Soc Lond B Biol Sci. 2001;356(1416):1871-6.
17. Liu STH, Behzadi MA, Sun W, Freyn AW, Liu WC, Broecker F, et al.
Antigenic sites in influenza H1 hemagglutinin display species-specific
immunodominance. J Clin Invest. 2018;128(11):4992-6.
18. Guarnaccia T, Carolan LA, Maurer-Stroh S, Lee RT, Job E, Reading PC,
et al. Antigenic drift of the pandemic 2009 A(H1N1) influenza virus in A
ferret model. PLoS Pathog. 2013;9(5):e1003354.
19. Fleury D, Wharton SA, Skehel JJ, Knossow M, Bizebard T. Antigen
distortion allows influenza virus to escape neutralization. Nat Struct
Biol. 1998;5(2):119-23.
20. Barbey-Martin C, Gigant B, Bizebard T, Calder LJ, Wharton SA, Skehel
JJ, et al. An antibody that prevents the hemagglutinin low pH fusogenic
transition. Virology. 2002;294(1):70-4.
21. Xu R, Ekiert DC, Krause JC, Hai R, Crowe JE, Jr., Wilson IA.
Structural basis of preexisting immunity to the 2009 H1N1 pandemic
influenza virus. Science. 2010;328(5976):357-60.
22. Oh D-Y, Buda S, Biere B, Reiche J, Schlosser F, Duwe S, et al.
Trends in respiratory virus circulation following COVID-19-targeted
nonpharmaceutical interventions in Germany, January - September 2020:
analysis of national surveillance data. Lancet Reg Health Eur.
2021;6:100112. doi: 10.1016/j.lanepe.2021.100112. PubMed PMID: 34124707;
PubMed Central PMCID: PMCPMC8183189.
Tables and Figures
Table 1: HA gene analysis of AH1N1)pdm09 viruses. The proportion of
novel HA variants in season 2019-2020 expressing cluster specific
substitutions in HA1 and HA2 is indicated. Additionally, the proportion
of viruses with reduced reactivity (>4-fold versus ≤4-fold)
in the hemagglutination inhibition test is shown.